Joseph Todisco Biography and Net Worth

CEO of CorMedix

Mr. Joe Todisco is Chief Executive Officer of CorMedix and a member of the Board of Directors. Prior to joining CorMedix, he spent eleven years in various roles at Amneal Pharmaceuticals, most recently as Chief Commercial Officer of Amneal Specialty, as well as Senior Vice President Corporate Development & International Operations. He was also co-founder and formerly chief executive of Gemini Laboratories LLC, a specialty pharmaceutical company that was subsequently acquired by Amneal. Prior to joining Amneal, Joe spent more than five years leading Ranbaxy Pharmaceutical’s North American Commercial Strategy and Business Development, and prior to Ranbaxy, held various leadership roles with Par Pharmaceuticals. Joe holds a bachelor’s degree in Economics from Georgetown University and an M.B.A. from Fordham Graduate School of Business.

What is Joseph Todisco's net worth?: The estimated net worth of Joseph Todisco is at least $5.42 million as of September 12th, 2025. Todisco owns 509,496 shares of CorMedix stock worth more than $5,421,037 as of December 5th. This net worth estimate does not reflect any other assets that Todisco may own. Additionally, Todisco receives a salary of $1,070,000.00 as CEO at CorMedix. Learn More about Joseph Todisco's net worth.
How old is Joseph Todisco?: Todisco is currently 47 years old. There are 3 older executives and no younger executives at CorMedix. Learn More on Joseph Todisco's age.
What is Joseph Todisco's salary?: As the CEO of CorMedix Inc, Todisco earns $1,070,000.00 per year. Learn More on Joseph Todisco's salary.
How do I contact Joseph Todisco?: The corporate mailing address for Todisco and other CorMedix executives is 300 CONNELL DRIVE SUITE 4200, BERKELEY HEIGHTS NJ, 07922. CorMedix can also be reached via phone at (908) 517-9500 and via email at [email protected]. Learn More on Joseph Todisco's contact information.
Has Joseph Todisco been buying or selling shares of CorMedix?: Joseph Todisco has not been actively trading shares of CorMedix during the last quarter. Most recently, Joseph Todisco sold 50,000 shares of the business's stock in a transaction on Friday, September 12th. The shares were sold at an average price of $13.00, for a transaction totalling $650,000.00. Following the completion of the sale, the chief executive officer now directly owns 509,496 shares of the company's stock, valued at $6,623,448. Learn More on Joseph Todisco's trading history.
Who are CorMedix's active insiders?: CorMedix's insider roster includes Elizabeth Hurlburt (EVP), Erin Mistry (EVP), and Joseph Todisco (CEO). Learn More on CorMedix's active insiders.
Are insiders buying or selling shares of CorMedix?: During the last twelve months, CorMedix insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $275,500.00. During the last twelve months, insiders at the sold shares 5 times. They sold a total of 163,997 shares worth more than $2,163,617.44. The most recent insider tranaction occured on October, 23rd when Director Myron Kaplan bought 25,000 shares worth more than $275,500.00. Insiders at CorMedix own 3.1% of the company. Learn More about insider trades at CorMedix.
Information on this page was last updated on 10/23/2025.

Joseph Todisco Insider Trading History at CorMedix

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/12/2025	Sell	50,000	$13.00	$650,000.00	509,496
3/13/2024	Buy	13,561	$3.74	$50,718.14	352,839
9/8/2023	Buy	10,000	$3.71	$37,100.00	219,726
11/15/2022	Buy	20,000	$3.82	$76,400.00	242,169
8/24/2022	Buy	4,700	$3.92	$18,424.00	222,169
5/16/2022	Buy	10,000	$3.38	$33,800.00	217,469

Joseph Todisco Buying and Selling Activity at CorMedix

CorMedix Company Overview

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Today's Range

Now: $10.64

$10.27

$10.76

50 Day Range

MA: $10.79

$9.40

$12.16

2 Week Range

Now: $10.64

$5.60

$17.43

Volume

2,462,511 shs

Average Volume

2,952,876 shs

Market Capitalization

$838.33 million

P/E Ratio

5.17

Dividend Yield

N/A

Beta

1.32

Joseph Todisco Biography and Net Worth

What is Joseph Todisco's net worth?

How old is Joseph Todisco?

What is Joseph Todisco's salary?

How do I contact Joseph Todisco?

Has Joseph Todisco been buying or selling shares of CorMedix?

Who are CorMedix's active insiders?

Are insiders buying or selling shares of CorMedix?